✦ LIBER ✦

1247 Phase I study of nimotuzumab, a humanized anti-epidermal growth factor receptor (EGFR) IgG1 monoclonal antibody in Japanese patients with solid tumors

✍ Scribed by N. Boku; K. Yamazaki; A. Fukutomi; T. Takahashi; N. Yamamoto; M. Miyazaki; T. Satoh; I. Okamoto; K. Nakagawa; M. Fukuoka

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of a phase I trial of the humani

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Phase II study of nimotuzumab, a humaniz

✍ Dirk Strumberg, Beate Schultheis, M. E. Scheulen, R. A. Hilger, J. Krauss, N. Ma 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 144 KB

732 POSTER Phase I clinical study of the

✍ J. Soriano; N. Batista; M. Lima; R. Rodríguez; M.V. López; A. Montenegro; M. Ram 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 83 KB

A phase I study of olaratumab, an anti-p

✍ Chiorean, E. Gabriela; Sweeney, Christopher; Youssoufian, Hagop; Qin, Amy; Donta 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 529 KB

A phase I study of the human monoclonal

✍ Weekes, Colin D.; Beeram, Muralidhar; Tolcher, Anthony W.; Papadopoulos, Kyriako 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 387 KB

Phase 1 study of ganitumab (AMG 479), a

✍ Haruyasu Murakami, Toshihiko Doi, Nobuyuki Yamamoto… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 228 KB